Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Firdapse (amifampridine) for the treatment of LEMS

Firdapse® (amifampridine) is a potassium channel blocker to treat Lambert-Eaton myasthenic syndrome (LEMS) in adults. Image courtesy of U.S. National Library of Medicine, National Institutes of Health, Health & Human Services.

  • Firdapse
  • Firdapse
  • Firdapse

Go Top